Related references
Note: Only part of the references are listed.Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis
Esther Shuyi Gan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Increased adaptive immune responses and proper feedback regulation protect against clinical dengue
Etienne Simon-Loriere et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design
James E. Crowe
CELL HOST & MICROBE (2017)
Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
Scott B. Halstead
EMERGING INFECTIOUS DISEASES (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Stephen S. Whitehead
EXPERT REVIEW OF VACCINES (2016)
A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone
Jorge E. Osorio et al.
EXPERT REVIEW OF VACCINES (2016)
Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine
Annelies Wilder-Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
Beth D. Kirkpatrick et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Impact of inflammatory cytokines on effector and memory CD8+T cells
Marie T. Kim et al.
FRONTIERS IN IMMUNOLOGY (2014)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Share Paper
